PetMed Express, Inc.: updates and filings

PETSNASDAQConsumer defensive · Retail-Drug Stores and Proprietary Stores

Price

$0.90

November 17, 2026Market cap $19M

What Ploutos Investor adds for PetMed Express

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 26% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.21 then, $0.90 on Nov 17, 2026). The figures date from before that move.10-Q

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 85 daysAround Feb 11, 2027 · for Q3 2027

last Nov 10, 2026next Feb 11, 2027

A rough estimate from when it has reported before, which has varied. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Jun 2, 2026 latest annualNov 10, 2026 latest quarterly
  • Nov 12, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 10, 2026Results of operations
    Form8-K
  • Sep 28, 2026Shares registered for employees
    FormS-8
  • Sep 28, 2026Shares registered for employees
    FormS-8
  • Sep 28, 2026Officer or director change
    Form8-K
  • Sep 21, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Sep 17, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 13, 2026Results of operations
    Form8-K
  • Aug 12, 2026Officer or director change, shareholder vote
    Form8-K
  • Jul 23, 2026Material agreement entered, Regulation FD disclosure
    Form8-K
  • Jun 29, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Jun 26, 2026Officer or director change
    Form8-K
  • Jun 25, 2026Additional annual meeting material
    FormDEFA14A
  • Jun 25, 2026Annual meeting proxy statement
    FormDEF 14A
  • Jun 2, 2026Annual reportfor the period to Mar 31, 2026
    Form10-K
  • Jun 2, 2026Results of operations
    Form8-K
  • May 21, 2026Material event
    Form8-K
  • Feb 11, 2026Over-5% holder statement (active)
    FormSCHEDULE 13D
  • Feb 5, 2026Quarterly reportfor the period to Dec 31, 2025
    Form10-Q
  • Jan 23, 2026Shareholder vote
    Form8-K
  • Dec 29, 2025Change of auditor (amendment)
    Form8-K/A
  • Dec 19, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 10, 2000.

The full analysis

What do PetMed Express's filings show?

The filings are where every one of PetMed Express's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.